Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria

Molecular Genetics and Metabolism

Volumn 82, Issue 1, 2004, Pages 76-82

  Gropper, Sareen S ^a   Yannicelli, Steven ^b   White, B Douglas ^a   Medeiros, Denis M ^c  

^a AUBURN UNIVERSITY   (United States)

^b Pharmavite LLC   (United States)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

Copper; Feces; Hyperphenylalaninemia; Intestine; Iron; Liver; Mice; Phenylketonuria; Zinc

Indexed keywords

COPPER; IRON; PHENYLALANINE; ZINC;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; COPPER METABOLISM; FECES ANALYSIS; FOOD INTAKE; INTESTINE; IRON METABOLISM; LIVER LEVEL; MALE; MOUSE; NONHUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN RESTRICTION; ZINC METABOLISM;

ANIMALS; COPPER; DIETARY PROTEINS; DISEASE MODELS, ANIMAL; FECES; INTESTINES; IRON; LIVER; MALE; MICE; ORGAN SIZE; PHENYLALANINE; PHENYLKETONURIAS; ZINC;

ANIMALIA; MURINAE;

EID: 1942489271     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2004.01.017     Document Type: Article

References (39)

1. Gropper S.S., Naglak M.C., Nardella M., Plyler A., Rarback S., Yannicelli S. Nutrient intakes of adolescents with phenylketonuria and infants and children with maple syrup urine disease on semisynthetic diets. J. Am. Coll. Nutr. 12:1993;108-114.
2. Gropper S.S., Acosta P.B., Clarke-Sheehan N., Wenz E., Cheng M., Koch R. Trace element status of children with PKU and normal children. J. Am. Diet. Assoc. 88:1988;459-465.
3. Acosta P.B. Nutrition studies in treated infants and children with phenylketonuria: vitamins, minerals, trace elements. Eur. J. Pediatr. 155:1996;S136-S139.
4. Gropper S.S., Trahms C., Cloud H.H., Isaacs J.S., Malinauskas B. Iron deficiency without anemia in children with phenylketonuria. Int. Pediatr. 9:1994;237-243.
5. Acosta P.B., Greene C., Yannicelli S., Korson M., Rohr F., Hooper L., Williams S., Mofidi S. Nutrition studies in treated infants with phenylketonuria. Int. Pediatr. 8:1993;63-73.
6. Bodley J.L., Austin V.J., Hanley W.B., Clarke J.T.R., Zlotkin S. Low iron stores in infants and children with treated phenylketonuria: a population at risk for iron-deficiency anaemia and associated cognitive deficits. Eur. J. Pediatr. 152:1993;140-143.
7. McMurry M.P., Chan G.M., Leonard C.O., Ernst S.L. Bone mineral status in children with phenylketonuria - relationship to nutritional intake and phenylalanine control. Am. J. Clin. Nutr. 55:1992;997-1004.
8. Miranda da Cruz B.D.O., Seidler H., Widhalm K. Iron status and iron supplementation in children with classical phenylketonuria. J. Am. Coll. Nutr. 12:1993;531-536.
9. van Bakel M.M.E., Printzen G., Wermuth B., Wiesmann U.N. Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am. J. Clin. Nutr. 72:2000;976-981.
10. Acosta P.B., Stepnick-Gropper S., Clarke-Sheehan N., Wenz E., Cheng M., Anderson K., Koch R. Trace element status of PKU children ingesting an elemental diet. JPEN. 11:1987;287-292.
11. Gropper S.S., Bader-Crowe D.M., McAnulty L.S., White B.D., Keith R.E. Non-anemic iron depletion, oral iron supplementation and indices of copper status in college-aged females. J. Am. Coll. Nutr. 21:2002;545-552.
12. Goldberg L., Smith J.P. Vitamin A deficiencies in relation to iron overload in the rat. J. Pathol. Bacteriol. 8:1960;173-180.
13. Mejia L.A., Hodges R.E., Rucker R.B. Role of vitamin A in the absorption, retention and distribution of iron in the rat. J. Nutr. 109:1979;129-137.
14. Roodenburg A.J.C., West C.E., Yu S., Beynen A.C. Comparison between time dependent changes in iron metabolism of rats as induced by marginal deficiency of either vitamin A or iron. Br. J. Nutr. 71:1994;687-699.
15. Sievers E., Oldigs H.D., Domer K. Trace element overload in PKU - diet? Pediatr. Res. 24:1988;270. (abstract).
16. Koch R., Wenz E. Phenylketonuria. Ann. Rev. Nutr. 7:1987;117-135.
17. Krause W., Haiminski M., McDonald L., Dembure P., Salvo R., Freides D., Elsas L. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria, a model for the study of phenylalanine and brain function in man. J. Clin. Invest. 75:1985;40-48.
18. Michals K., Matalon R. Phenylalanine metabolites, attention span and hyperactivity. Am. J. Clin. Nutr. 42:1985;361-365.
19. Al-Qadreh A., Schulpis K.H., Athanasopoulou H., Mengreli C., Skarpalezou A., Voskaki I. Bone mineral status in children with phenylketonuria under treatment. Acta Paediatr. 87:1998;1162-1166.
20. Azen C.G., Koch R., Friedman E.G., Barlow S., Goldwell J., Krause W., Matalon R., McCabe E., O'Flynn F., Peterson R. Intellectual development in 12-year-old children treated for phenylketonuria. Am. J. Dis. Child. 145:1991;35-39.
21. Fisch R.O., Matalon R., Weisberg S., Michals K. Phenylketonuria: current dietary treatment practices in the United States and Canada. J. Am. Coll. Nutr. 16:1997;147-151.
22. Gleason L.A., Michals K., Matalon R., Langenberg P., Kamath S. A treatment program for adolescents with phenylketonuria. Clin. Pediatr. 31:1992;331-335.
23. Schulz B., Bremer H.J. Nutrient intake and food consumption of adolescents and young adults with phenylketonuria. Acta Paediatr. 84:1995;743-748.
24. Wendel U., Langenbeck U. Towards self-monitoring and self-treatment in phenylketonuria - a way to better diet compliance. Eur. J. Pediatr. 155(Suppl. 1):1996;S105-S107.
25. Yannicelli S., Medeiros D. Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice. J. Inherit. Metab. Dis. 25:2000;347-361.
26. Russell W.L., Kelly E.M., Hunsicker P.R., Bangham J.W., Maddax S.C., Phipps E.L. Specific locos tests shows ethylnitrosourea to be most potent mutagen in the mouse. Proc. Natl. Acad. Sci. USA. 76:1979;5818-5819.
27. HPH-5: a mouse mutant deficient in phenylalanine hydroxylase. Proc. Natl. Acad. Sci. USA. 87:1990;1965-1967.
28. Bell J.M., John A.M. Amino acid requirements of growing mice: arginine, lysine, tryptophan and phenylalanine. J. Nutr. 111:1981;525-530.
29. Hirakawa D.A., Olson L.M., Baker D.H. Comparative utilization of a crystalline amino acid diet and a methionine-fortified casein diet by young rats and mice. Nutr. Res. 4:1984;891-895.
30. Maddy K.H., Elevelhjem C.A. Studies on growth of mice fed rations containing free amino acids. J. Biol. Chem. 177:1949;577-590.
31. Casey C.E., Walravens P.A., Hambidge K.M. Availability of zinc: loading tests with human milk, cow's milk, and infant formulas. Pediatrics. 68:1981;394-396.
32. Xue Q., Aliabadi H., Hallfrisch J. Effects of dietary galactose and fructose on rats fed diets marginal or adequate in copper for 9-21 months. Nutr. Res. 7:2001;1078-1087.
33. Berry H.K., Bofinger M.K., Hunt M.M., Philips P.J., Guifoile M.K. Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine, and leucine. Pediatr. Res. 16:1982;751-755.
34. Berry H.K., Brunner R.L., Hunt M.M. Valine, isoleucine, and leucine: a new treatment for phenylketonuria. Am. J. Dis. Child. 144:1990;539-543.
35. Butler I.J., O'Flynn M.E., Seifert W.E., Howell R.R. Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia. J. Pediatr. 98:1981;729-733.
36. Diamond A., Ciaramitaro V., Donner E., Djali S., Robinson M.B. An animal model of early-treated PKU. J. Neurosci. 14:1994;3072-3082.
37. Lou H.C., Lykkelund C., Gerdes A.M., Udesen H., Bruhn P. Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatr. Scand. 76:1987;560-565.
38. McKean C.M. The effects of high phenylalanine concentration on serotonin and catecholamine metabolism in the human brain. Brain Res. 47:1972;469-476.
39. van Spronsen F.J., Paans A.M.J., Willemsen A.T.M., Smit G.P.A. PKU treatment beyond childhood. The use of positron emission tomography to design a well-balanced treatment. J. Inherit. Metab. Dis. 22(Suppl.):1999;1-2. (abstract).